About This Course

Made in collaboration with Myeloma UK, this eLearning course is for healthcare professionals. It has been designed to teach you everything you need to know about monoclonal gammopathy of unknown significance (MGUS). Topics include epidemiology, pathophysiology, diagnosis, and monitoring.

Myeloma UK is the only charity in the UK that focuses on the blood cancer myeloma and its related conditions. This patient association support research to treat myeloma as well as support patients who suffer from myeloma.

This course should take you approximately 60 minutes to complete.



This course has been accredited by the Royal College of Physicians and awarded 1 CPD point.


------------

This course has a 2-year expiry date of 25 March 2026. If you complete this course after its expiry date, please double check all claims in this course with up-to-date, peer-reviewed information, as the diagnostic or treatment landscape may have changed.  

------------

Learning Outcomes

By the end of this course, learners will be able to:

  • describe the epidemiology, aetiology and pathophysiology of MGUS.

  • explain why MGUS needs to be accurately diagnosed, risk assessed and monitored.

  • list who can play a role in the monitoring of MGUS.

  • summarise the criteria for risk stratification of patients with MGUS.

  • confidently identify the optimal monitoring strategy for a patient with MGUS.

Course curriculum

    1. Welcome to the Course

    1. Introduction to Pre-Course Quiz

    2. Pre-Course Quiz

    1. What is MGUS?

    1. Why the Need for MGUS Monitoring?

    1. How to Monitor MGUS

    1. Improving Patient Outcomes

    1. Introduction to Quiz

    2. Final Quiz

    1. Conclusions and Take-Home Messages

    2. Helpful Resources

    3. Course Feedback Survey

About this course

  • Free
  • 12 lessons
  • 0 hours of video content

Expert Faculty

Dr. Karthik Ramasamy, Associate Professor of Haematology & Consultant Haematologist, Oxford University Hospitals NHS Trust, UK

Dr. Jenny Bird, Consultant Haematologist, Bristol Haematology and Oncology Centre, UK

Dr. Mark Drayson, Emeritus Professor of Clinical Immunodiagnostics and Consultant Immunologist, University Hospital Birmingham & Heartlands Hospital, UK

Dr. Jennifer Pinney, Consultant Nephrologist, University Hospitals Birmingham NHS Foundation Trust, UK

Ms. Lisa Ferguson, Myeloma Senior Specialist Nurse, Oxford University Hospitals NHS Foundation Trust, UK

Dr. Simon Stern, Consultant Haematologist, Epsom & St. Helier University Hospitals NHS Trust, UK

Certificate
Multimedia
Text
Survey
Quiz
FREE
Enroll course